1 results match your criteria: "3 Department of Internal Medicine of University of Athens[Affiliation]"
Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study.
Anticancer Res
May 2024
Sotiria General Hospital of Chest Disease, 3 Department of Internal Medicine of University of Athens, Oncology Unit, Athens, Greece.
Background/aim: Lung cancer, primarily non-small cell lung cancer (NSCLC), is the leading cause of cancer deaths globally. In Greece in 2020, 8,960 new cases were reported. NSCLC's 5-year survival rates range from 54% (stage I) to less than 2% (stage IV); however, innovative therapies like immune check points inhibitors (ICIs) and targeted treatments have notably enhanced outcomes.
View Article and Find Full Text PDF